Susquehanna International Group’s Redhill Biopharma RDHL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-23
Closed -$11K 13460
2022
Q3
$11K Buy
23
+1
+5% +$871 ﹤0.01% 12761
2022
Q2
$19K Sell
22
-27
-55% -$37K ﹤0.01% 12378
2022
Q1
$124K Sell
49
-84
-63% -$199K ﹤0.01% 11748
2021
Q4
$342K Sell
133
-9
-6% -$36K ﹤0.01% 10171
2021
Q3
$650K Sell
142
-25
-15% -$170K ﹤0.01% 8711
2021
Q2
$1.15M Sell
167
-72
-30% -$497K ﹤0.01% 7375
2021
Q1
$1.75M Buy
239
+86
+56% +$721K ﹤0.01% 6242
2020
Q4
$1.24M Buy
153
+47
+44% +$422K ﹤0.01% 6202
2020
Q3
$1.08M Buy
106
+51
+93% +$418K ﹤0.01% 5907
2020
Q2
$371K Buy
55
+43
+358% +$296K ﹤0.01% 7962
2020
Q1
$53K Hold
12
﹤0.01% 9663
2019
Q4
$75K Sell
12
-6
-33% -$38.3K ﹤0.01% 9237
2019
Q3
$130K Buy
+18
New +$131K ﹤0.01% 9414

Other funds holding RDHL

Susquehanna International Group's RDHL Position: Q1 2023 in Review

Susquehanna International Group sold out of Redhill Biopharma (RDHL) in Q1 2023, closing a stake of 16 shares — an estimated $3.02K sold.

Susquehanna International Group first reported a position in RDHL in Q3 2019 and held it in 14 quarters. The position peaked at $2.15M in Q1 2021. 16 funds tracked by Wall St. Rank hold RDHL as of Q1 2023.

  • Susquehanna International Group reported no remaining Redhill Biopharma position as of Q1 2023 after selling out during the quarter.
  • Susquehanna International Group sold 16 Redhill Biopharma shares in Q1 2023, an estimated $3.02K.
  • Susquehanna International Group first reported a position in Redhill Biopharma in Q3 2019 and held it in 14 quarters.
  • Susquehanna International Group's Redhill Biopharma position peaked at $2.15M in Q1 2021.
  • 16 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.